Therapy of Kaposi's sarcoma in AIDS.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000628:therapy; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005047:Etoposide / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D007370:Interferon Type I / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D011379:Prognosis; D012107:Research Design; D012514:Sarcoma, Kaposi / Q000150:complications* / Q000628:therapy; D014747:Vinblastine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D007370:Interferon Type I; D007376:Interleukin-2; D014747:Vinblastine; D005047:Etoposide